WINDTREE THERAPEUTICS INC /DE/ Write off of Deferred Debt Issuance Cost
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Write off of Deferred Debt Issuance Cost of $66.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2016-03-29
- WINDTREE THERAPEUTICS INC /DE/ write off of deferred debt issuance cost for fiscal 2015 was $66.00K.
- WINDTREE THERAPEUTICS INC /DE/ write off of deferred debt issuance cost for fiscal 2014 was $0.00.
| Period end | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|
| 2015-12-31 | $66.00K 10-K · filed 2016-03-29 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |